Decreased lipoprotein (a) and serum high-sensitivity C-reactive protein levels in male patients with atherosclerosis after supplementation with ginger: A randomized controlled trial

سال انتشار: 1399
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 142

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_RYA-16-4_001

تاریخ نمایه سازی: 2 شهریور 1401

چکیده مقاله:

BACKGROUND: Although the antioxidant properties of ginger have been revealed, there is little available information on the effectiveness of ginger on inflammatory disorders such as atherosclerosis. This study was carried out to examine the effect of ginger on improving the complication of atherosclerosis.METHODS: This study was a double-blind, placebo-controlled, randomized clinical trial conducted on patients with atherosclerosis. Participants in the ginger and control groups received ۱۶۰۰ mg of powdered ginger or placebo (wheat flour) in capsules daily for ۸ weeks. Weight, body mass index (BMI), fasting blood sugar (FBS), cholesterol, triglyceride (TG), low-density lipoprotein (LDL), very-low-density lipoprotein (VLDL), high-density lipoprotein (HDL), lipoprotein (a) [Lp(a)], high-sensitivity C-reactive protein (hs-CRP), and total anti-oxidant capacity (TAC) were assessed before and after the intervention.RESULTS: Ginger consumption in the intervention group significantly reduced serum Lp(a) level (۲۷.۲۵ ± ۱.۳۰ ng/ml vs. ۲۳.۵۷ ± ۰.۹۷ ng/ml) (P = ۰.۰۴۰) and also the level of hs-CRP in the intervention group was ۱.۹۰ ± ۰.۳۳ µg/ml and ۱.۲۴ ± ۰.۱۵ µg/ml (P = ۰.۰۱۰) before and after intervention, respectively, but the levels of Lp(a) and hs-CRP were not decreased significantly in the placebo group. The level of TAC in the ginger group was ۰.۷۱ ± ۰.۰۵ mM and after the trial was ۰.۵۷ ± ۰.۰۴ mM (P = ۰.۰۵۰); no significant differences were seen in TAC when ginger was administered at ۱۶۰۰ mg/daily for ۶۰ days. Also the level of Lp(a) and hs-CRP but not TAC reduced significantly in ginger group compared to placebo group after intervention.CONCLUSION: This study showed that ginger had anti-atherosclerosis and anti-glycemic properties associated through a significant decreased Lp(a) and FBS in patients with atherosclerosis supplemented with ginger.

کلیدواژه ها:

Atherosclerosis ، Ginger ، Lipoprotein (a) ، C-Reactive Protein ، Oxygen Radical Absorbance Capacity

نویسندگان

Hossein Babaahmadi-Rezaei

Associate Professor, Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Alireza Kheirollah

Associate Professor, Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Saeed Hesam

Assistant Professor, Department of Biostatistics and Epidemiology, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Saleh Ayashi

PhD Candidate, Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Mohammad Aberumand

Associate Professor, Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Mohammad Hassan Adel

Associate Professor, Atherosclerosis Research Center AND Department of Cardiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Masoumeh Zamanpour

Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Maryam Alasvand

Assistant Professor, Atherosclerosis Research Center AND Department of Cardiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Zohreh Amozgari

Lecturer, Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Mojgan Noor-Behbahani

Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

Zahra Niknam

Cellular and Molecular Research Center AND Department of Clinical Biochemistry, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl ...
  • Mackay J, Mensah GA. The atlas of heart disease and ...
  • Libby P. What have we learned about the biology of ...
  • Nordestgaard BG, Chapman MJ, Ray K, Boren J, Andreotti F, ...
  • Raal FJ, Giugliano RP, Sabatine MS, Koren MJ, Blom D, ...
  • Kassner U, Schlabs T, Rosada A, Steinhagen-Thiessen E. Lipoprotein(a)An independent ...
  • Kooti W, Mansouri E, Ghasemiboroon M, Harizi M, Ashtary-Larky D, ...
  • Mitra B, Panja M. High sensitive C-reactive protein: A novel ...
  • Wang Y, Chun OK, Song WO. Plasma and dietary antioxidant ...
  • Werneke U, Earl J, Seydel C, Horn O, Crichton P, ...
  • Grzanna R, Lindmark L, Frondoza CG. Gingeran herbal medicinal product ...
  • Jiang X, Blair EY, McLachlan AJ. Investigation of the effects ...
  • Frostegard J. SLE, atherosclerosis and cardiovascular disease. J Intern Med ...
  • Tietge UJ. Hyperlipidemia and cardiovascular disease: Inflammation, dyslipidemia, and atherosclerosis. ...
  • Shirali S, Shokri Mashhadi N, Ashtary-Larky D, Safania T, Barari ...
  • Kooti W, Hasanzadeh-Noohi Z, Sharafi-Ahvazi N, Asadi-Samani M, Ashtary-Larky D. ...
  • Goyal RK, Kadnur SV. Beneficial effects of Zingiber officinale on ...
  • Mozaffari-Khosravi H, Talaei B, Jalali BA, Najarzadeh A, Mozayan MR. ...
  • Ali BH, Blunden G, Tanira MO, Nemmar A. Some phytochemical, ...
  • Sharpe PA, Granner ML, Conway JM, Ainsworth BE, Dobre M. ...
  • Koba S, Hirano T. Dyslipidemia and atherosclerosis. Nihon Rinsho ۲۰۱۱; ...
  • Nicoll R, Henein MY. Ginger (Zingiber officinale Roscoe): A hot ...
  • Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zingiber ...
  • Kooti W, Farokhipour M, Asadzadeh Z, Ashtary- Larky D, Asadi-Samani ...
  • Shidfar F, Rajab A, Rahideh T, Khandouzi N, Hosseini S, ...
  • Danesh J, Collins R, Peto R. Lipoprotein(a) and coronary heart ...
  • Bennet A, Di Angelantonio E, Erqou S, Eiriksdottir G, Sigurdsson ...
  • Tsimikas S. Lipoprotein(a): Novel target and emergence of novel therapies ...
  • Bos S, Yayha R, van Lennep JE. Latest developments in ...
  • Norata GD, Ballantyne CM, Catapano AL. New therapeutic principles in ...
  • Ghafourian M, Ashtary-Larky D, Chinipardaz R, Eskandary N, Mehavaran M. ...
  • Arablou T, Aryaeian N, Valizadeh M, Sharifi F, Hosseini A, ...
  • Mansouri E, Ghasemiboroon M, Asadi Samani M, Alamiri F, Ashtary-Larky ...
  • Stoilova I, Krastanov A, Stoyanova A, Denev P, Gargova S. ...
  • Kamato D, Babaahmadi Rezaei H, Getachew R, Thach L, Guidone ...
  • نمایش کامل مراجع